DEA Removes Fenfluramine From Controlled Substances List
The Drug Enforcement Administration is removing fenfluramine from schedule IV of the Controlled Substances Act, it said in a notice of the final rule in the Dec. 23 Federal Register. The DEA said the drug has no abuse potential. The…
Sign up for a free preview to unlock the rest of this article
Timely, relevant coverage of court proceedings and agency rulings involving tariffs, classification, valuation, origin and antidumping and countervailing duties. Each day, Trade Law Daily subscribers receive a daily headline email, in-depth PDF edition and access to all relevant documents via our trade law source document library and website.
removal eliminates “the regulatory controls and administrative, civil, and criminal sanctions applicable to controlled substances, including those specific to schedule IV controlled substances, on persons who handle (manufacture, distribute, reverse distribute, dispense, engage in research, import, export, conduct instructional activities or chemical analysis with, or possess) or propose to handle fenfluramine,” the DEA said. The delisting is effective Dec. 23.